Discover 190 paid clinical trials in North Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
North Dakota offers many paid research opportunities statewide, giving healthy volunteers and individuals with specific health needs access to a wide range of clinical studies. Key cities like Fargo, Bismarck, and Grand Forks are home to research centers actively recruiting participants, offering access to the latest treatments and medical advancements.
Filter
1
Filter results
Results: 190
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
for
Pruritus
Location: New York NY, Verdun, Baltimore MD, Washington D.C. DC,
Sponsor: Sanofi
Sex: All
Age: 18 - 70+
Code: NCT05263206
Phase3, Recruiting
Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
for
Chronic Lymphocytic Leukemia
Location: Cranston RI, Mount Kisco NY, Elizabeth NJ,
Sponsor: East Valley Hematology and Oncology Medical Group
Sex: All
Age: 18+
Code: NCT00131313
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Microbiome and Bariatric Surgery
for
Weight Change, Body
Location: Cleveland OH, Fargo ND
Sponsor: North Dakota State University
Sex: All
Age: 18 - 65
Code: NCT03065426
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease